NCT05831111 2025-09-30A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1195, in 18- to 55-Year-Old Healthy ParticipantsModernaTX, Inc.Phase 1 Active not recruiting482 enrolled
NCT05164094 2025-05-15A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1189, in 10- to 30-Year-Old Healthy Adolescents and AdultsModernaTX, Inc.Phase 1/2 Active not recruiting867 enrolled